Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4RIU

A Carbonic Anhydrase IX Mimic in Complex with a Saccharin-Based Inhibitor

Summary for 4RIU
Entry DOI10.2210/pdb4riu/pdb
Related4RIV
DescriptorCarbonic anhydrase 2, ZINC ION, GLYCEROL, ... (5 entities in total)
Functional Keywordscarbonic anhydrase fold, reversible hydration of co2, active site point mutations, cytosolic, lyase-lyase inhibitor complex, lyase/lyase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm : P00918
Total number of polymer chains1
Total formula weight29984.98
Authors
Mahon, B.P.,McKenna, R. (deposition date: 2014-10-07, release date: 2015-02-04, Last modification date: 2023-09-20)
Primary citationMahon, B.P.,Hendon, A.M.,Driscoll, J.M.,Rankin, G.M.,Poulsen, S.A.,Supuran, C.T.,McKenna, R.
Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.
Bioorg.Med.Chem., 23:849-854, 2015
Cited by
PubMed Abstract: Carbonic anhydrase IX (CA IX) is a key modulator of aggressive tumor behavior and a prognostic marker and target for several cancers. Saccharin (SAC) based compounds may provide an avenue to overcome CA isoform specificity, as they display both nanomolar affinity and preferential binding, for CA IX compared to CA II (>50-fold for SAC and >1000-fold when SAC is conjugated to a carbohydrate moiety). The X-ray crystal structures of SAC and a SAC-carbohydrate conjugate bound to a CA IX-mimic are presented and compared to CA II. The structures provide substantial new insight into the mechanism of SAC selective CA isoform inhibition.
PubMed: 25614109
DOI: 10.1016/j.bmc.2014.12.030
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.651 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon